Shi Siyao Group announced in Hong Kong that it has obtained approval from the China National Drug Administration for drug production registration for vitamin K1 injections. It is a Class 3 chemical drug, which is deemed to have passed the consistency evaluation. Vitamin K1 injections are mainly used to treat bleeding due to vitamin K deficiency and prevent vitamin K deficiency that cannot be obtained through nutritional supplementation.

Shi Siyao Group announced in Hong Kong that it has obtained approval from the China National Drug Administration for drug production registration for vitamin K1 injections. It is a Class 3 chemical drug, which is deemed to have passed the consistency evaluation. Vitamin K1 injections are mainly used to treat bleeding due to vitamin K deficiency and prevent vitamin K deficiency that cannot be obtained through nutritional supplementation.